Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis … – PR Newswire

Transaction is part of wide-ranging collaboration to combine Quest’s oncology expertise and scale with PathAI’s AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs SECAUCUS, N.J. and BOSTON, May 1, 2024 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), a leader Read More